Un aspect méthodologique particulier des études de pharmaco-épidémiologie et de pharmaco-économie : Expression et interprétation des consommations médicamenteuses

Journal d'Economie Medicale

Volumn 14, Issue 1, 1996, Pages 15-34

  Goubier Vial, C ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Drug consumption; Drug cost indicators; Drug statistics; Methodology; Pharmacoeconomy; Pharmacoepidemiology

Indexed keywords

DRUG USE; HEALTH CARE COST; HUMAN; PHARMACOECONOMICS; PHARMACOEPIDEMIOLOGY; REVIEW;

EID: 0029873417     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Aguiar E, Cavalcante MDA, Salinas LF, Romualdo C, Ferreira MA, Amorim VLF, Carneiro DMN. Controle do consumo de antimicrobianos no Hospital de Base do Distrito Federal. Rev Ass Med Brasil 1986;32:118-122.
2. Baksaas I. Patterns in drug utilization - national and international aspects : antihypertensive drugs. Acta Med Scand 1984;683Suppl.:59-66.
3. Begaud B, Abenheim L, Fourrier A, Haramburu F, Miremont G, Moride Y, Pere JC, Tubert P. Analyse d'incidence en pharmacovigilance. Application à la notification spontanée. ARME-Pharmacovigilance Eds, Bordeaux, 1992, Seconde Edition, pp 53-78.
4. Bergman U. The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 1975;8:83-89.
5. Bergman U, Christenson I, Jansson B, Wiholm BE. Auditing hospital drug utilisation by means of defined daily doses per bedday. A methodological study. Eur J Clin Pharmacol 1980;17:183-187.
6. Bergman U, Sjöqvist F. Measurement of drug utilization in Sweden : methodological and clinical implications. Acta Med Scand 1984;683suppl.:15-22.
7. Berod T, Mulot F, Beaugendre E, Chakhtoura F. Prescription et consommation d' oméprazole. Surveillance sur 10 mois après la mise en place de recommandations de bon usage. Lyon Pharm 1993;44:173-177.
8. Boethius G. Approaches to assessing the rationality of drug usage in a developed country. Acta Med Scand 1988;suppl.721: 21-26.
9. Clarke KW, Gray D. The Defined Daily Dose as a tool in pharmacoeconomics. Advantages and limitations. PharmacoEconomics 1995;7:280-283.
10. Demichelis C, Braguer D, Bongrand MC, Perez R. Evolution de la consommation d' antibiotiques au groupe hospitalier de la Timone. J Pharm Clin 1988;7:511-522.
11. Fourastie J, Grais B. Les indices statistiques. Masson Eds, Paris, 1984.
12. e Edition, Maloine Eds, Paris, 1985.
13. Gladen HE. Evaluating the cost-effectiveness of treatment with third-generation cephalosporins. Diag Microbiol Infect Dis 1992;15:99-105.
14. Holbein MEB, Crane VS. Cephalosporin confusion-one simple solution ? Am J Hosp Pharm 1991;48:236.
15. Lapeyre-mestre M, Chave B, Rascol O, Senard JM, Lafont J, Montastruc JL. Evolution de la consommation des antibiotiques au CHRU de Toulouse de 1980 à 1989. Thérapie 1992;47:57-6.
16. Lapeyre-mestre M, Lebret-bories E, Charlet JP, Montastruc JL, Montastruc P. Consommation de médicaments dans une population de sujets d' âge scolaire. Thérapie 1991; 46:49-53.
17. Le Pen C, Pele A. Croissance de la consommation pharmaceutique : illusion statistique sur le médicament ? Décision Santé 1992;26:25-31.
18. Lunde PKM, Baksaas I. Epidemiology of drug utilization - Basic concepts and methodology. Acta Med Scand 1988;suppl.721: 7-11.
19. Lunde PKM, Baksaas I, Halse M, Halvorson IK, Stromnes B, Oydvin K. The methodology of drug utilisation. WHO Regional Office Publications, European Series 1979;8:17-28.
20. Maison C, Mery D, Durand JL. Gestion d' une pharmacie hospitalière. Gest Hasp 1990;292:28-32.
21. Mehl B. Indicators to control drug costs in hospitals. Am J Hosp Pharm 1984;41:667-675.
22. Mehl B. Inflation index and weighted drug index. Hasp Pharm 1987;22:916-918.
23. Miller DE. Coping with DRGs : Hospital of the University of Pennsylvania, Philadelphia. Am J Hosp Pharm 1983;40:1503-1504.
24. Moreland TA, Rylance GW, Christopher LJ, Stevenson IH. Patterns of drug prescribing for children in hospital. Eur J Clin Pharmacol 1978;14:39-46.
25. Mouton RP, Hermans J, Simoons-Smit AM, Hoogkamp-Korstanjen JAA, Degener JE, Van Klingeren B. Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci. J Antimicrob Chemother 1990;26: 573-583.
26. Murphy Enright S. Understanding Prospective Pricing and DRGs. Am J Hosp Pharm 1983;40:1493-1494.
27. Nordic Council on Medicines. Guidelines for ATC classification. WHO Collaborating Centre for Drug Statistics Methodology Eds, Oslo (Norway), 1990:pp188.
28. Norrby SR. Consumption of antibiotics in Sweden, 1975 to 1992. Pharmacoeconomic and clinical aspects. Pharmacoeconomics 1992;2:238-244.
29. Petersson C, Hakansson A. A prospective study of infectious morbidity and antibiotic consumption among children in different forms of municipal day-care. Scand J Infect Dis 1989;21:449-457.
30. Ponge T, Cottin S, Fruneau P, Ponge A, Van Wassenhove L, Larousse C. Evaluation de la consommation médicamenteuse des sujets hospitalisés. Enquête prospective. Thérapie 1989;44:59-62.
31. Prince AK. Identifying disease drug-cost indicators using diagnosis-related groups. Am J Hosp Pharm 1986;43:1503-1504.
32. Roncalez D, Grelaud G, Malcus C, Chaulet JF, Garin D, Renard C. Maîtrise de l' antibiothérapie par l' évaluation, l' éducation, et la communication. Pharm Hosp Fr 1992;101:873-886.
33. Sacristan JA, Soto J. Drug Utilisation Studies as tools in Health Economics. PliarmacoEconomics 1994;5:299-312.
34. Sanders DH, Murph AF, Eng RJ. Les statistiques, une approche nouvelle. McGraw-Hill, Montréal, 1984.
35. Schlienger JL, Schlienger M, Grunenberger F. Evolution de la prescription médicamenteuse entre 1989 et 1991 dans une population gériatrique vivant è domicile. Sem Hop Paris 1992;22-23:645-649.
36. Shihab Eldeen A, Araj GF, Thulesius O, Skold O, Chugh TD, Salah EA, Elmardi NA. A comparison of antibiotics consumption and bacterial resistance patterns in Kuwait and Sweden. APMIS 1988;suppl.3: 59-62.
37. Stolar MH. Developing drug-use indicators with a computerized drug data base and a personal computer software package. Am J Hosp Pharm 1987;44:1075-1086.
38. Strom BL. Pharmacoepidemiology. John WILEY & sons Ltd Eds, Chichester (England), 1994, Seconde Edition.
39. Strom BL, Morse ML. Use of computerized databases to survey drug utilization in relation to diagnoses. Acta Med Scand 1988;suppl.721:13-20.
40. Taboulet F. Présentation d' une méthodologie permettant de mesurer en quantité et de comparer les consommations pharmaceutiques. J Econ Med 1990;8:37-63.
41. e Edition.
42. Wertheimer A. The defined daily dose system (DDD) for drug utilization review. Hosp Pharn 1986;21:233-258.
43. Wessling A, Boethius G. Measurement of drug use in a defined population. Evaluation of the Defined Daily Dose (DDD) methodology. Eur J Clin Pharmacol 1990;39: 207-210.
44. World Health Organization. The selection of essential drugs. Technical Report Series 641, Geneva, 1979.
45. World Health Organization. Drug Utilization Studies. Methods and uses. WHO Regional Office Publications, European Series 45, MNG Dukes Eds, 1993:pp218.